Adenocarcinoma of the Pancreas Recruiting Phase 2 Trials for Leucovorin (DB00650)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03977233Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic CancerTreatment
NCT03822936Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas AdenocarcinomaTreatment
NCT01897454Combination Chemotherapy, Gemcitabine Hydrochloride, and Radiation Therapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic CancerTreatment